"Glioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Descriptor ID |
D005910
|
| MeSH Number(s) |
C04.557.465.625.600.380 C04.557.470.670.380 C04.557.580.625.600.380
|
| Concept/Terms |
Glioma- Glioma
- Gliomas
- Glial Cell Tumors
- Glial Cell Tumor
- Tumor, Glial Cell
- Tumors, Glial Cell
Mixed Glioma- Mixed Glioma
- Glioma, Mixed
- Gliomas, Mixed
- Mixed Gliomas
Malignant Glioma- Malignant Glioma
- Glioma, Malignant
- Gliomas, Malignant
- Malignant Gliomas
|
Below are MeSH descriptors whose meaning is more general than "Glioma".
Below are MeSH descriptors whose meaning is more specific than "Glioma".
This graph shows the total number of publications written about "Glioma" by people in this website by year, and whether "Glioma" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 19 | 2 | 21 |
| 1995 | 23 | 7 | 30 |
| 1996 | 21 | 7 | 28 |
| 1997 | 21 | 8 | 29 |
| 1998 | 20 | 4 | 24 |
| 1999 | 23 | 7 | 30 |
| 2000 | 31 | 3 | 34 |
| 2001 | 30 | 7 | 37 |
| 2002 | 33 | 8 | 41 |
| 2003 | 42 | 7 | 49 |
| 2004 | 32 | 7 | 39 |
| 2005 | 49 | 7 | 56 |
| 2006 | 50 | 10 | 60 |
| 2007 | 50 | 7 | 57 |
| 2008 | 38 | 2 | 40 |
| 2009 | 55 | 7 | 62 |
| 2010 | 55 | 7 | 62 |
| 2011 | 56 | 5 | 61 |
| 2012 | 72 | 9 | 81 |
| 2013 | 68 | 4 | 72 |
| 2014 | 90 | 9 | 99 |
| 2015 | 83 | 13 | 96 |
| 2016 | 84 | 7 | 91 |
| 2017 | 90 | 4 | 94 |
| 2018 | 81 | 11 | 92 |
| 2019 | 73 | 12 | 85 |
| 2020 | 91 | 8 | 99 |
| 2021 | 89 | 1 | 90 |
| 2022 | 98 | 0 | 98 |
| 2023 | 81 | 0 | 81 |
| 2024 | 63 | 6 | 69 |
Below are the most recent publications written about "Glioma" by people in Profiles.
-
Co-evolution of glioma and immune microenvironment. J Immunother Cancer. 2024 Dec 03; 12(12).
-
Utility of OLIG2 immunostaining in pediatric brain tumors with embryonal morphology. J Neuropathol Exp Neurol. 2024 Dec 01; 83(12):1039-1046.
-
The QIBA Profile for Dynamic Susceptibility Contrast MRI Quantitative Imaging Biomarkers for Assessing Gliomas. Radiology. 2024 Dec; 313(3):e232555.
-
Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in glioma. Nat Commun. 2024 Nov 21; 15(1):10089.
-
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas. Neuro Oncol. 2024 Nov 04; 26(11):2044-2060.
-
Glioma immune microenvironment composition calculator (GIMiCC): a method of estimating the proportions of eighteen cell types from DNA methylation microarray data. Acta Neuropathol Commun. 2024 Oct 28; 12(1):170.
-
Pseudo-Resting-State Functional MRI Derived from Dynamic Susceptibility Contrast Perfusion MRI Can Predict Cognitive Impairment in Glioma. AJNR Am J Neuroradiol. 2024 Oct 03; 45(10):1552-1561.
-
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors? Neuro Oncol. 2024 Oct 03; 26(10):1805-1822.
-
Genome-wide polygenic risk scores predict risk of glioma and molecular subtypes. Neuro Oncol. 2024 Oct 03; 26(10):1933-1944.
-
A brave new framework for glioma drug development. Lancet Oncol. 2024 Oct; 25(10):e512-e519.